Skip to main content
elexxion AG logo

elexxion AG — Investor Relations & Filings

Ticker · EX8 ISIN · DE000A0KFKH0 LEI · 391200ZATSWUACIZBU38 F Manufacturing
Filings indexed 149 across all filing types
Latest filing 2017-09-18 Annual Report
Country DE Germany
Listing F EX8

About elexxion AG

https://www.elexxion.com/en/

elexxion AG is a technology company that develops, produces, and sells dental laser systems. Its product portfolio includes diode lasers and Er:YAG lasers for both soft and hard tissue applications. Key offerings include the high-power claros® series, with models providing up to 50 watts for surgical procedures, the compact elexxion pico laser, and the perio green® photothermal therapy (PTT) for treating periodontology and peri-implantitis. The company's technology is designed for dental practitioners seeking to perform a wide range of treatments with precision.

Recent filings

Filing Released Lang Actions
Jahresabschluss 2016
Annual Report Classification · 100% confidence The document is titled 'Geschäftsbericht 2016' (Annual Report 2016) and contains comprehensive financial data, a management letter, a balance sheet, a profit and loss statement, and an auditor's note. It covers the full fiscal year 2016 and provides a detailed analysis of the company's performance, strategy, and outlook. It is clearly the primary annual financial report of the company. FY 2016
2017-09-18 German
elexxion AG: Increase in Shareholding of Major Shareholder / Modification term of the Appointment of Management Board Member Martin Werner Klarenaar
Major Shareholding Notification Classification · 95% confidence The document is an 'Ad-hoc' announcement dated September 1, 2017, disclosing inside information according to Article 17 MAR. The content primarily discusses two key events: 1) An increase in shareholding by a major shareholder (Tian Ying Medical Instrument Co., Ltd.) involving the acquisition of a 30% stake and a related investment, and 2) A modification to the term of appointment for a Management Board Member. While it mentions the new date for the Annual General Meeting will be announced later, the core subject matter relates to significant changes in ownership structure and management terms. This type of announcement, dealing with insider transactions (major shareholding change) and management changes, fits best under the 'Major Shareholding Notification' (MRQ) or potentially 'Board/Management Information' (MANG). Since the primary focus is the acquisition of a significant stake (30% leading to a majority holding), MRQ is the most specific fit for the ownership change aspect, which is detailed first. The management change is secondary to the ownership restructuring. It is not an ER, CT, or 10-K. Given the explicit mention of 'Increase in Shareholding of Major Shareholder', MRQ is the most appropriate classification.
2017-09-01 English
elexxion AG verschiebt Veroffentlichung des Jahresabschlusses und die ordentliche Hauptversammlung fur das Geschaftsjahr 2016
Report Publication Announcement Classification · 99% confidence The document is an 'Ad-hoc' announcement dated June 28, 2017, from elexxion AG. The core content states that the company is postponing the publication of its annual financial statements ('Jahresabschlusses') for fiscal year 2016 and the Annual General Meeting ('ordentliche Hauptversammlung'). This is an announcement about future corporate actions and financial reporting deadlines, not the reports themselves. Since it is an official announcement regarding corporate events and financial reporting schedules, it fits best under the general category for regulatory announcements that don't fit a more specific financial report type. Given the nature of the announcement (postponement of AGM and financial results), it is a regulatory disclosure. It is not a specific financial report (10-K, IR), a dividend notice (DIV), or a management change (MANG). It is a general regulatory announcement, making 'RNS' (Regulatory Filings) the most appropriate fallback, although 'AGM-R' relates to the postponed event, the document itself is the announcement of the postponement, not the AGM material. Since it is a formal, time-sensitive disclosure under MAR (Market Abuse Regulation), RNS is the best fit as a general regulatory filing notice.
2017-06-28 German
elexxion AG: Gerichtliche Bestellung eines Aufsichtsratsmitgliedes
Board/Management Information Classification · 100% confidence The document is an 'Ad-hoc' announcement dated June 12, 2017, titled 'elexxion AG: Gerichtliche Bestellung eines Aufsichtsratsmitgliedes' (Court Appointment of a Supervisory Board Member). It explicitly discusses the appointment of a new member to the Supervisory Board (Aufsichtsrat) following a resignation. This directly relates to changes in the company's board of directors or senior management structure. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is short (2157 chars), but it is the primary announcement itself, not an announcement *about* a report, so the RPA rule does not apply.
2017-06-12 German
elexxion AG: Wechsel des Groaktionars
Major Shareholding Notification Classification · 99% confidence The document is an 'Ad-hoc' announcement dated December 21, 2016, published via DGAP (a service for regulatory news). It details significant corporate events: a change in major shareholder (acquisition of 55% stake by Tian Ying Medical Instrument Co., Ltd), confirmation of the CEO's term, resignation of a Supervisory Board member, and a revised revenue forecast for 2016. These events relate to ownership structure changes, management appointments, and financial outlook updates, but they do not constitute a full Annual Report (10-K), an Earnings Release (ER), or a formal Capital/Financing Update (CAP) detailing the terms of the investment, although investment is mentioned. The core content is a mix of governance changes and material non-public information disclosure, typical of a general regulatory disclosure. Since it is an immediate, material announcement that doesn't fit the specific categories like DIRS, DIV, or DLST, and it is not a presentation (IP) or a transcript (CT), the most appropriate general regulatory category is Regulatory Filings (RNS), which serves as the fallback for miscellaneous mandatory disclosures under MAR (Market Abuse Regulation, referenced by 'Insiderinformation gemäß Artikel 17 MAR').
2016-12-21 German
elexxion AG: Tian Ying Medical Instrument Co., Ltd beteiligt sich als neuer Ankerinvestor
M&A Activity Classification · 99% confidence The document is a short announcement (2643 characters) classified as 'Ad-hoc' and dated 28 October 2016. The content details a significant change in ownership where Tian Ying Medical Instrument Co., Ltd is acquiring a majority stake (approx. 55%) in elexxion AG from the current major shareholder. This involves a change in control and capital structure, but it is presented as an immediate notification ('Insiderinformation gemäß Artikel 17 MAR'). Since it describes a major corporate transaction involving acquisition/takeover, it strongly aligns with the M&A Activity category (TAR). It is not a full report, nor is it a standard management change or dividend notice. It is a specific announcement about a transaction.
2016-10-28 German

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.